Poulvac® Procerta® HVT-IBD-ND

Trivalent vector vaccine against Marek's disease, IBD and Newcastle disease

Recombinant HVT serotype 3 with VP2 (IBD) and F (Newcastle disease) genes
Protection against Marek's disease, IBD and Newcastle disease — single product
In ovo (18–19 days) or subcutaneous injection to day-old chicks

Available as

Frozen vaccine

For use with

Poultry (chickens)

Strength

Recombinant HVT-3 (IBD VP2 + NDV F gene)

How it is supplied

5 × 4,000 doses

Learn more

Drug description

Vector Vaccine POULVAC® PROCERTA® HVT-IBD-ND

Poulvac® Procerta® HVT-IBD-ND is a modified live vector frozen vaccine. Composition: frozen cell-associated live viral vaccine containing recombinant turkey herpesvirus serotype 3 with VP2 gene of IBD virus and F gene of Newcastle disease virus.

Established efficacy for vaccination of healthy day-old chicks or in ovo vaccination of 18–19-day embryonated chicken eggs against Marek's disease, infectious bursal disease and Newcastle disease.

Route of administration: in ovo or subcutaneous injection. Packaging: 5 × 4,000 doses.

Start cooperation with industry leaders